Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use

Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use

US Patent 9636337 · Granted May 2, 2017

Estimated economic value: $258,821,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclopentapyrrole orexin receptor agonists2025
Tetrahydroquinazoline derivatives as selective cytotoxic agents2025
2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors2025
2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors2025
Pyrrolidine orexin receptor agonists2025
Heteroaryl pyrrolidine and piperidine orexin receptor agonists2025
Pyrimidone derivatives as selective cytotoxic agents against HIV infected cells2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcho2024